Morgan Stanley restated their overweight rating on shares of MetLife ( NYSE:MET – Free Report ) in a research note issued to investors on Thursday morning, Benzinga reports. The firm currently has a $78.00 price objective on the financial services provider's stock. Other equities research analysts have also issued reports about the stock. TheStreet lowered shares of MetLife from a b- rating to a c+ rating in a research report on Wednesday, May 24th. Wells Fargo & Company boosted their target price on MetLife from $72.

https://www.dailypolitical.com/2023/08/06/metlife-nysemet-earns-overweight-rating-from-morgan-stanley.html

#dailypolitical